Astrid Kiermaier
- Oncology top 2%
- Molecular Biology top 10%
- Pulmonary and Respiratory Medicine top 5%
- Radiology, Nuclear Medicine and Imaging top 5%
- Cancer Research top 5%
- Co-authors
- Martin EilersSandra M. SwainJosé BaselgaEmma ClarkJavier CortésGraham RossJoan MassaguéTarik Möröy
- Topics
- HER2/EGFR in Cancer Research (18 papers)Monoclonal and Polyclonal Antibodies Research (9 papers)Cancer Immunotherapy and Biomarkers (7 papers)
- Partner nations
- SwitzerlandGermanyUnited Kingdom
In The Last Decade
Astrid Kiermaier
29 papers receiving 2.2k citations
Hit Papers
Peers
Comparison fields: 5 of 85
- Oncology 1.5k
- Molecular Biology 957
- Pulmonary and Respiratory Medicine 569
- Radiology, Nuclear Medicine and Imaging 474
- Cancer Research 424
Countries citing papers authored by Astrid Kiermaier
This map shows the geographic impact of Astrid Kiermaier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Astrid Kiermaier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Astrid Kiermaier more than expected).
Fields of papers citing papers by Astrid Kiermaier
This network shows the impact of papers produced by Astrid Kiermaier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Astrid Kiermaier. The network helps show where Astrid Kiermaier may publish in the future.
Co-authorship network of co-authors of Astrid Kiermaier
This figure shows the co-authorship network connecting the top 25 collaborators of Astrid Kiermaier. A scholar is included among the top collaborators of Astrid Kiermaier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Astrid Kiermaier. Astrid Kiermaier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 35 | |
| 2 | 34 | |
| 3 | 2 | |
| 4 | 15 | |
| 5 | 9 | |
| 6 | 58 | |
| 7 | 4 | |
| 8 | 144 | |
| 9 | 76 | |
| 10 | 210 | |
| 11 | 1 | |
| 12 | 2 | |
| 13 | HER2 screening data from ToGA: targeting HER2 in gastric and gastroesophageal junction cancerbreakdown → | 426 |
| 14 | 260 | |
| 15 | 64 | |
| 16 | 46 | |
| 17 | 465 | |
| 18 | 269 | |
| 19 | 22 | |
| 20 | 20 |
About Astrid Kiermaier
Astrid Kiermaier is a scholar working on Oncology, Cancer Research and Radiology, Nuclear Medicine and Imaging, having authored 29 papers that have together received 2.3k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (18 papers), Monoclonal and Polyclonal Antibodies Research (9 papers) and Cancer Immunotherapy and Biomarkers (7 papers). The work is most often cited by research in Oncology (1.5k citations), Cancer Research (424 citations) and Radiology, Nuclear Medicine and Imaging (474 citations). Astrid Kiermaier has collaborated with scholars based in Switzerland, Germany and United Kingdom. Frequent co-authors include Martin Eilers, Sandra M. Swain, José Baselga, Emma Clark, Javier Cortés, Graham Ross, Joan Massagué, Tarik Möröy, F. Hänel and Holger Karsunky. Their work appears in journals such as Journal of Clinical Oncology, Genes & Development and Nature Cell Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.